ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Survival"

  • 2022 American Transplant Congress

    Sirolimus Regimens After Kidney Transplantation: Role of Pre-Transplant Risk Factors in Modifying the Risk of Mortality in Adult Recipients

    A. Santos1, H. Ibrahim1, M. A. Leghrouz1, X. Wen2

    1University of Florida, Gainesville, FL, 2University of Rhode Island, Kinston, RI

    *Purpose: We aimed to investigate the role of risk factors in modifying the association of sirolimus with mortality in kidney transplant (KT) recipients (KTRs).*Methods: Using…
  • 2022 American Transplant Congress

    Liver Transplantation in Patients with Portal Vein Thrombosis: Implications and Outcomes

    D. Noguchi, C. J. Rosenthal, M. Ha, V. G. Agopian, D. G. Farmer, F. M. Kaldas

    Liver and Pancreas Transplant Center, UCLA, Los Angeles, CA

    *Purpose: Preoperative bland portal vein thrombosis (PVT) is common in Liver transplant (LT) candidates and has been suspected to negatively impact post-LT outcomes, however studies…
  • 2022 American Transplant Congress

    Four-Year Patient Survival After Simultaneous Pancreas-Kidney Transplantation According to Graft Status Using Kaplan-Meier Survival Method and Competing Risk Model

    L. A. Alfaro1, L. A. Viana1, M. P. Cristelli1, E. B. Rangel2, R. Meirelles3, H. Tedesco1, J. Medina1

    1Renal Transplantation, Hospital do Rim - Fundação Oswaldo Ramos, Sao Paulo, Brazil, 2Federal University of Sao Paulo, Sao Paulo, Brazil, 3Kidney-Pancreas Transplantation, Hospital do Rim - Fundação Oswaldo Ramos, Sao Paulo, Brazil

    *Purpose: Aim of this study is to compare the patient survival submitted to SPKT according to the status of graft losses, kidney, pancreas, or both…
  • 2022 American Transplant Congress

    Clinical Impact of a Modified Lung Allocation Score That Mitigates Selection Bias

    E. M. Schnellinger1, E. Cantu2, D. E. Schaubel1, S. E. Kimmel3, A. J. Stephens-Shields1

    1University of Pennsylvania, Philadelphia, PA, 2Hospital of the University of Pennsylvania, Philadelphia, PA, 3University of Florida, Gainesville, FL

    *Purpose: The U.S. lung allocation system uses the Lung Allocation Score (LAS) to prioritize lung transplant candidates. Selection bias, induced by dependent censoring of waitlisted…
  • 2022 American Transplant Congress

    Re-Kidney Transplantation in Patients with Graft Failure: Survival Benefit by Age

    J. Ahn1, S. Sandal2, A. Massie1, D. Segev1, M. Cantarovich2, M. McAdams-DeMarco1

    1Johns Hopkins University, Baltimore, MD, 2McGill University, Montreal, QC, Canada

    *Purpose: As the rates of kidney transplantation (KT) have doubled over the past three decades, so has the proportion of patients who experience graft failure…
  • 2022 American Transplant Congress

    Evolution of the Need for Transplant Evaluations for Liver Failure Decompensation After TIPS

    N. Kemmer1, V. Sureshkumar2, L. Grater3, G. Hoots4, S. Agrawal1, K. Robichaux5, M. Gosselin3, S. Mohammed5, A. Kumar6, J. Buggs7

    1Transplant Hepatology, Tampa General Hospital, Tampa, FL, 2Lake Erie College of Osteopathic Medicine, Bradenton, FL, 3University of Tampa, Tampa, FL, 4Radiology, Tampa General Hospital, Tampa, FL, 5University of South Florida, Tampa, FL, 6Morsani College of Medicine, University of South Florida, Tampa, FL, 7Transplant Surgery, Tampa General Hospital, Tampa, FL

    *Purpose: Portal hypertension is described as an increased pressure gradient between the portal and systemic circulation which can result in severe complications. Transjugular Intrahepatic Portosystemic…
  • 2022 American Transplant Congress

    The Gut Microbiome in the Critical Care Setting Post-Heart Transplantation

    M. Dela Cruz1, H. Lin2, E. Adler2, M. Khalid2, J. Boissiere2, G. Kim1, S. Pinney1, E. Pamer2, A. Nguyen1

    1Section of Cardiology, University of Chicago, Chicago, IL, 2Duchossois Family Institute, University of Chicago, Chicago, IL

    *Purpose: Given its potential impact on immune activation and systemic inflammation, we aim to investigate gut microbiome compositions and metabolites during critical illness in the…
  • 2022 American Transplant Congress

    Similar Outcomes in Type 2 Diabetic vs Type 1 Diabetics Receiving Simultaneous Kidney Pancreas Transplantation

    P. Budhiraja1, H. Me1, J. Ninan2, S. Reddy2, S. S. Misra1, R. Heilman1, H. Khamash1, K. Reddy1, C. Jadloweic1, N. Katariya1, H. Chakkera1

    1Mayo Clinic, Phoenix, AZ, 2Mayo Clinic, Rochester, MN

    *Purpose: Combined kidney-pancreas transplant remains an optimal choice for type 1 diabetics with kidney failure. The benefit for those with type 2 diabetes, however, remains…
  • 2022 American Transplant Congress

    Impact of Belatacept on Clinical Outcomes in Lung Transplant Patients with Antibody-Mediated Rejection

    L. Zaffiri, R. Hallak, S. Leonard, M. Neely, A. Hulber, H. Berry, K. A. Young, J. M. Reynolds

    Duke University, Durham, NC

    *Purpose: Antibody-mediated rejection (AMR) is cause of significant morbidity and mortality in lung transplant recipients (LTRs). An optimal therapeutic regimen is still lacking. Recent evidence…
  • 2022 American Transplant Congress

    Association of Pre-Transplant Anti A1 IgM Antibody Titers with Survival Outcomes in A2/A2B to B Kidney Transplantation

    M. Fallahzadeh, D. Shaffer, A. El Chediak, I. Feurer, S. Rega, J. L. Triozzi, S. Shawar

    Vanderbilt University Medical Center, Nashville, TN

    *Purpose: The new kidney allocation system implemented in 2014 has allowed blood type B recipients to receive kidneys from A2/A2B donors. Although many centers use…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • …
  • 66
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences